KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Gains from Investment Securities (2016 - 2025)

Humana has reported Gains from Investment Securities over the past 17 years, most recently at -$151.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$151.0 million for Q4 2025, up 70.96% from a year ago — trailing twelve months through Sep 2025 was -$369.0 million (up 4.65% YoY), and the annual figure for FY2024 was $50.0 million, changed.
  • Gains from Investment Securities for Q4 2025 was -$151.0 million at Humana, down from $122.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for HUM hit a ceiling of $675.0 million in Q2 2023 and a floor of -$957.0 million in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $7.5 million (2021), compared with a mean of $51.8 million.
  • Biggest five-year swings in Gains from Investment Securities: soared 2876.92% in 2021 and later crashed 13771.43% in 2023.
  • Humana's Gains from Investment Securities stood at $8.0 million in 2021, then fell by 12.5% to $7.0 million in 2022, then crashed by 13771.43% to -$957.0 million in 2023, then soared by 45.66% to -$520.0 million in 2024, then soared by 70.96% to -$151.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were -$151.0 million (Q4 2025), $122.0 million (Q3 2025), and $41.0 million (Q2 2025) per Business Quant data.